Skip to content

PHARMACTION

Active Private limited companyfounded 2017active for 9 yearsBerthelotstraat 106, 1190 ForestKBO/BCE: BE 0671.515.855
PHARMACTION
Follow ReportCompare

Overview

Lifetime

8 annual accounts with figures on one time axis
peak €28,360 (2025)
€28,360▲ 26.2%
lowest -€3,383 (2018)
€19,582▲ 23.7%
peak €86,954 (2025)
€86,954▲ 29.1%
€203,918▼ 0.1%
Board2 names since 2017
2 directorsMarc PUISSANT BAEYENS and 1 other
Owners2 names in the annual accounts
30%PROFIELD
Documentsfilings and deeds
30-11-202562 days before the deadline
2025micro format
Gross margin from €22,478 to €28,360Equity from €67,373 to €86,954Cash from €29,904 to €5,916

Key points

from the 2025 annual accounts

Equity

€86,954 ▲ 29.1%

PHARMACTION has made a profit without a break since 2019.

Debts

€203,918 70% of the balance sheet
Suppliers 92%Taxes and wages 4%Other 4%

Checked score

83
Excellent
Financially stronger than 42% of micro companies in advertising and market research (NACE 73)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: 0.2% across 11,228 companies (NACE 73, micro).

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.5% 01-2025: 0.6%▲ +0.1 percentage points vs 12-2024highest value 02-2025: 0.3%▼ -0.3 percentage points vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.3%● unchanged vs 06-2025lowest value 08-2025: 0.3%● unchanged vs 07-2025lowest value 09-2025: 0.3%● unchanged vs 08-2025lowest value 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.4%▲ +0.1 percentage points vs 09-2026 11-2026: 0.4%● unchanged vs 10-2026

Financial strength
Average

55+5equity 29.9% of total assets
15-8short-term debt 70.1% · cash 2.0%
77+1return on assets 6.7%

Score breakdown

raises risk
Liquidity: current ratio 1.42, cash €5,916, halved
lowers risk
Size: total assets €290,873
Sector: Advertising, market research and public relations activities (NACE 73)
Figures for financial year 2025 (filed on 05-12-2025)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 73, micro). It does better than 34% of them on solvency, 9% on liquidity, 50% on profitability and 75% on growth.

The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 30-06-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 6,713 companies had the same profile as PHARMACTION has now. Each dot stands for 17 companies, two years later.

95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of PHARMACTION itself is lower: 0.4% within 12 months. It rests on far more data about PHARMACTION than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,713 companies, not a prediction for PHARMACTION. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €7,000 on 30-day terms is acceptable

Liquidity is tight, with a current ratio of 1.42 (1.32 in 2024), below the usual 1.5. Short-term debt is 70.1% and cash 2% of total assets. 70.1% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €290,873
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Sector: Advertising, market research and public relations activities (NACE 73)
KBO
raises risk · Liquidity: current ratio 1.42, cash €5,916, halved
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 05-12-2025)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-11-2025, 62 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
62 days early
2024
8 days early
2023
35 days early
2022
49 days early
2021
4 days early
2020
18 days late
2019
10 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 19 days before the deadline. In the sector (NACE 73), the median for financial year 2024 was 6 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 27 December (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end09-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

MP
Marc PUISSANT BAEYENS
Chair
SC
Sébastien COLIN
Managing director
  • PROFIELD 30%score 89equity €906,815 (2025) · 2025 annual accounts of PROFIELD
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0671515855
Appointments: Marc PUISSANT BAEYENS (managing director) and Sébastien COLIN (managing director) General meeting of 21-12-2023 · Gazette deed
Incorporation published on 17-02-2017 · Gazette deed
First establishment Berthelotstraat 106, Forest
All 14 events

Comparable companies

same main activity, similar in size and age
Company
PHARMACTION Forest €290,873 €28,360 29.9% -
SMART.COM Couvin €280,801 €24,311 30.0% -
Casa Blu Uccle €301,545 €27,139 38.5% -
BD-EM Hamme (Vl.) €260,989 €38,858 66.3% -
ContentMoon Antwerp €284,583 €19,303 10.1% -
martijnknoops.be Oudsbergen €231,758 €37,773 53.9% -
UW IDEE Tongeren-Borgloon €356,022 €35,891 25.1% -

These companies have the same main activity as PHARMACTION: advertising agencies (NACE 73110). They are comparable in size and age: total assets between €232,000 and €356,000, founded between 2013 and 2017.

Official details

Source: KBO
Status
Active since 15-02-2017Normal situation
Registered office
19 active companies are registered at this address3 started in the 12 months before. Source: KBO register, as of 9 November 2026.
Activity
Advertising agenciesNACE 73110and 1 other
Establishment unit
2.262.617.8421190 Forest, since 15-02-2017
Financial year end
30 June
Peppol
Reachable since 21-10-2026
Company details

Annual accounts to 30-06-2025

€28,360▲ 26.2%
≈ €75,000estimated
€19,582▲ 23.7%
€86,954▲ 29.1%
€290,873▲ 7.2%
Filing
Filed on 30-11-2025, 62 days before the end of the filing period
Financials

Insights on PHARMACTION

PHARMACTION files the micro format. That format states no turnover. The gross margin rose from €3,482 in 2018 to €28,360 in 2025.

In May 2024, the Official Gazette published the appointment of Marc PUISSANT BAEYENS as managing director.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

micro format, filed on 30-11-2025, 62 days before the deadline
€28,360
▲ 26.2%
€26,973
▲ 25.0%
€19,582
▲ 23.7%
€85,463
▲ 31.7%
29.9%
▲ 5.1 percentage points
1.42
▲ 0.10

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €75,000. Estimated: probably between €53,000 and €100,000.

Balance sheet

balance sheet total €290,873 on 30-06-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

29.9%

Higher than 32% of 8,614 companies in 2025.

1.42

Higher than 37% of 8,290 companies in 2025.

6.7%

Higher than 42% of 8,399 companies in 2025.

PHARMACTION Middle half of the sector 80% of the sector Micro accounts in advertising and market research (NACE 73)

Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024202320222021202020192018
Balance sheet: assets
20/58 290,873271,430175,07999,07195,11551,11533,25063,349
21/28 1,4922,492--6,00012,00018,00024,000
21 1,4922,492--6,00012,00018,00024,000
29/58 289,381268,939175,07999,07189,11539,11515,25039,349
40/41 283,465239,034161,71771,27677,95736,49513,36336,988
40 277,892236,465159,74270,76377,95736,2949,41831,805
41 5,5732,5691,975513-2013,9455,183
54/58 5,91629,90412,46227,79511,1582,6201,8872,361
490/1 --900-----
Balance sheet: equity and liabilities
10/49 290,873271,430175,07999,07195,11551,11533,25063,349
10/15 86,95467,37351,53737,77528,41119,11615,49715,167
10/11 20,40520,40518,55018,55018,55018,55018,55018,550
10 ---18,550----
100 ---18,55018,55018,55018,55018,550
13 --1,8551,855100100--
130/1 --1,8551,855100100--
130 ---1,855100100--
1311 --1,855-----
14 66,54946,96831,13217,3709,761466-3,053-3,383
17/49 203,918204,058123,54261,29666,70431,99917,75348,182
42/48 203,918204,058123,54261,12266,53031,82617,57948,008
44 188,147198,362122,95457,55661,87619,3065,45935,888
440/4 188,147198,362122,95457,55661,87619,3065,45935,888
46 8,424-------
45 7,3485,6955873,5464,634400--
450/3 7,3485,6955873,5464,634400--
47/48 ---202012,12012,12012,120
492/3 ---174174173174174
Income statement
9900 28,36022,47818,89018,91119,05110,3886,7073,482
630 1,000508-6,0006,0006,0006,0006,000
640/8 387384348348348348356848
9901 26,97321,58618,54212,56312,7034,040351-3,366
75/76B 1-0-----
75 1-0-----
65/66B 44351923724222117
65 4435192-----
66B ---3724222117
9903 26,93021,55118,35012,52612,6794,018330-3,383
67/77 7,3485,7164,5873,1633,384399--
9904 19,58215,83513,7629,3639,2953,619330-3,383
9905 19,58215,83513,7629,3639,2953,619330-3,383
Appropriation of the result
9906 66,54946,96831,13219,1259,761566-3,053-3,383
14P 46,96831,13217,3709,762----
691/2 ---1,755-100--
6920 ---1,755-100--
Document PDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 30-11-2025.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
30-06-2025 micro format 30-11-2025 2025-00576333 PDF
30-06-2024 micro format 23-01-2025 2025-00009036 PDF
30-06-2023 micro format 27-12-2023 2023-00537543 PDF
30-06-2022 micro format 13-12-2022 2022-20536244 PDF
30-06-2021 micro format 27-01-2022 2022-02500521 PDF
30-06-2020 micro format 18-02-2021 2021-05600471 PDF
30-06-2019 micro format 10-02-2020 2020-04800177 PDF
30-06-2018 micro format 12-01-2019 2019-01200470 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024202320222021202020192018
27,97222,094-18,56318,70310,0406,3512,634
20,58216,343-15,36315,2959,6196,3302,617
03,000-000030,000
-23,98817,442-15,33316,6378,538733-474-
85,46364,88151,53737,94922,5857,289-2,329-8,659
29.9%24.8%29.4%38.1%29.9%37.4%46.6%23.9%
1.421.321.421.621.341.230.870.82
2.353.032.401.622.351.671.153.18
22.5%23.5%26.7%24.8%32.7%18.9%2.1%-22.3%
6.7%5.8%7.9%9.5%9.8%7.1%1.0%-5.3%
over 100over 100-over 100----

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item30-06-202530-06-202430-06-202330-06-2022
Intangible fixed assets-€3,000--
€1,000€508-€6,000

Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)

Insights on PHARMACTION

The operating result for 2025 is 25% higher than in 2024 and the highest since 2018. It is the third rise in a row, after the fall in 2022.

Debt's share of the balance-sheet total falls from 75.2% to 70.1%. Equity is higher and debt is lower.

Board & ownership

Board

2 directors, 2 in day-to-day management, last change in 2024
Marc PUISSANT BAEYENS
Chair of the board and managing director
appointed by deed of 16-05-2024 term without a fixed end
listed in the 2025 annual accounts, filed on 30-11-2025
Sébastien COLIN
Managing director
appointed by deed of 16-05-2024 term without a fixed end
listed in the 2025 annual accounts, filed on 30-11-2025
Marc PUISSANT BAEYENS, Sébastien COLIN
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“mandat de l’administrateur coopté prend fin après l’assemblée générale, sans que cela porte préjudice à la régularité de la composition de…”
deed of 16-05-2024

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
Marc PUISSANT BAEYENS
Managing director, Chair of the board
Sébastien COLIN
Managing director
LeadershipBoard
Mandates as a list
  • Marc PUISSANT BAEYENS
    • Managing director, from 15-02-2017 to date
    • Chair of the board, appointed by deed of 16-05-2024, still in office
    • Managing director, appointed by deed of 16-05-2024, still in office
  • Sébastien COLIN
    • Managing director, from 15-02-2017 to date
    • Managing director, appointed by deed of 16-05-2024, still in office

See the board, name and registered office on a given date →

Control

Shareholder
PROFIELD
Equity €906,815
Profit €503,833 in 2025 (profit €303,039 in 2024)
Checked score 89
Source: accounts PROFIELD 2025
30%
This company
PHARMACTION
Equity €86,954
Profit €19,582 in 2025

Capital

Contribution
€20,405
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
PROFIELD
30%
30%
MPB COMPANY
40%
40% until 2020
Owners as a list

Source: lists of holdings in the owners' accounts

Articles of association

deed of 16-05-2024 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
“1. générale ordinaire se réunit chaque année à l'initiative de l’organe d’administration ou des commissaires au siège de la société ou à…”

Network & group

No group

PHARMACTION has no parent and no holdings in its annual accounts.

At the same address

Berthelotstraat 106, 1190 Forest · 18 other companies
Poké House
registered office since 01-08-2020 · founded in 2018
 71 FTE (2025)
0699.927.254
IDKLIC
registered office since 06-04-2006 · founded in 2006
 8.3 FTE (2025)
0880.133.557
FORCADO
registered office since 07-05-2015 · founded in 2014
 18 FTE (2025)
0550.873.787
FORCADO UCCLE
registered office since 21-11-2018 · founded in 2018
 7.9 FTE (2025)
0713.753.318
SEASON IMMO
registered office since 12-09-2003 · founded in 2003
 turnover €700,259 (2025)
0860.465.917
POP POT
registered office since 17-10-2018 · founded in 2018
 total assets €361,161 (2025)
0711.776.102
BO AND BOWL
registered office since 30-03-2021 · founded in 2021
 total assets €202,161 (2025)
0765.824.601
M&N GLOBAL FOOD
registered office since 12-01-2021 · founded in 2021
 turnover €119,898 (2025)
0761.470.883
Club Tonnerre
registered office since 25-04-2018 · founded in 2018 · negative equity (2025)
 total assets €104,615 (2025)
0694.692.026
ASSURE
registered office since 28-07-2005 · founded in 2005
 total assets €95,256 (2025)
0874.656.918
and 8 more

Connections & network

2 current directors
Depth

The network starts from the directors of PHARMACTION. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Timeline

14 events since 2017

Deadline for the 2026 accounts: 31-01-2027

2026
Registered in the Peppol Directory Reachable for e-invoices through 0208:0671515855
2025
Annual accounts 2025 filed PDFmicro format · 62 days before the deadline
Highest result from 2018 to 2025 net €19,582 ▲23.7% The operating result of €26,973 and the net result of €19,582 are both a record.
Annual accounts 2024 filed PDFmicro format · 8 days before the deadline
2024
Appointments: Marc PUISSANT BAEYENS (managing director) and Sébastien COLIN (managing director)General meeting of 21-12-20234 points ▸

Open the deed in the Belgian Official Gazette

2023
Annual accounts 2023 filed PDFmicro format · 35 days before the deadline
2022
Annual accounts 2022 filed PDFmicro format · 49 days before the deadline
Annual accounts 2021 filed PDFmicro format · 4 days before the deadline
2021
Annual accounts 2020 filed PDFmicro format · 18 days late
2020
Annual accounts 2019 filed PDFmicro format · 10 days late
2019
Back to profit net €330 The net result is €330, after one loss-making year.
Annual accounts 2018 filed PDFmicro format · 19 days before the deadline
2017
Incorporation PDFpublished on 17-02-2017
First establishment Berthelotstraat 106, Forest

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

PHARMACTION was incorporated on 15 February 2017.1 Total assets rose from €33,250 in 2019 to €290,873 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2019 and 2025

Company details

Identity

Enterprise number
0671.515.855
VAT number
BE 0671.515.855
Peppol ID
0208:0671515855
Legal form
Private limited company
Status
Active, normal situation
Founded
15-02-2017
Financial year
ends on 30 June
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
“1. générale ordinaire se réunit chaque année à l'initiative de l’organe d’administration ou des commissaires au siège de la société ou à…”
deed of 16-05-2024 (in French)
Peppol
Reachable since 21-10-2026Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
PHARMACTION in French
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 16-05-2024 (in French)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Région de Bruxelles-Capitale”
deed of 16-05-2024 (in French)

Activities

NACEBEL 2025
73110 Advertising agencies main activity
82200 Office administrative, office support and other business support activities
Codes under NACEBEL 2008
73110 Advertising, market research and public relations activities main activity
82200 Office administrative, office support and other business support activities
PurposeThe purpose describes the activities the company may carry out under its articles.
“Le conseil en stratégie; L'assistance et le conseil en marketing et promotion des ventes; L'étude,la conception,le…”
3 activities
  1. Le conseil en stratégie
  2. L'assistance et le conseil en marketing et promotion des ventes
  3. L'étude,la conception,le développement,l'organisation et l'implémentation de campagnes de promotion
deed of 16-05-2024 (in French)

Registered office and establishments

1 establishment
Establishment Since Unit number
Berthelotstraat 106 registered office 1190 Forest 15-02-2017 2.262.617.842

Buildings and parcels at the address

Ground area
1,259 m²
Buildings
1,300 m²
Volume, LiDAR
10,305 m³
Tallest building
12.6 m
Buildings to scale, each on its own parcel
1,300 m², 12.6 m 1,300 m², 12.6 m

Location

registered office establishment The establishment unit on the map
19 companies at this address See who is registered here

Parcels

Cadastral parcelArea Buildings Height / floors
21007A0039/00B0041,259 m² 1 · 1,300 m² 12.6 m · 3

We would like to set cookies. That happens only with your consent. What we measure